A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial

Peer Review reports

Original Submission
4 Dec 2007	Submitted	Original manuscript
5 Dec 2007	Author responded	Author comments - Jorge Sierra
Resubmission - Version 2
5 Dec 2007	Submitted	Manuscript version 2
10 Jan 2008	Reviewed	Reviewer Report - Yu Shyr
28 Jan 2008	Reviewed	Reviewer Report - Leslie Huson
11 Mar 2008	Author responded	Author comments - Jorge Sierra
Resubmission - Version 3
11 Mar 2008	Submitted	Manuscript version 3
9 May 2008	Reviewed	Reviewer Report - Yu Shyr
10 Jun 2008	Author responded	Author comments - Jorge Sierra
Resubmission - Version 4
10 Jun 2008	Submitted	Manuscript version 4
27 Jun 2008	Author responded	Author comments - Jorge Sierra
Resubmission - Version 5
27 Jun 2008	Submitted	Manuscript version 5
Resubmission - Version 6
	Submitted	Manuscript version 6
4 Jul 2008	Author responded	Author comments - Jorge Sierra
Resubmission - Version 7
4 Jul 2008	Submitted	Manuscript version 7
Publishing
10 Jul 2008	Editorially accepted
10 Jul 2008	Article published	10.1186/1471-2407-8-195

Back to article page